The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 2nd 2025
Despite benefits for reducing drug costs, community oncology practices face the unintended consequences of the IRA.
What to Know About Working with PBMs
February 20th 2018A Pharmacy Benefit Manager (PBM) is a third party administrator contracted by health plans, employers, unions and government entities to manage prescription drug programs. A PBM acts as a fiscal intermediary between insurers/payors and pharmacies.
Read More
Durvalumab Approved by FDA for Reducing NSCLC Progression
February 19th 2018The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation.
Read More